Communiqués U.S. Stem Cell, Inc.

Actions

USRM

US90350U1007

Recherche biotechnologique et médicale

Temps Différé OTC Markets 18:16:22 16/09/2026			Varia. 5j.	Varia. 1 janv.
0,000100 ^USD	0,00%		0,00%	+9 900,00%

14/04/23	U.S. Stem Cell, Inc. présente ses résultats pour l'exercice clos le 31 décembre 2022	CI
14/04/23	L'auditeur de U.S. Stem Cell, Inc. L'auditeur émet des doutes sur la continuité de l'exploitation	CI

Communiqués

14/04/23	U.S. STEM CELL, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	AQ
09/11/22	NOTE 2 - GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS	AQ
08/07/22	U.S. STEM CELL, INC. - 10-K/A - Management's Discussion and Analysis of Financial Condition and Results of Operations	AQ
23/05/22	NOTE 2 - GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS	AQ
31/03/22	U.S. STEM CELL, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	AQ
09/03/22	U S Stem Cell : Material Event - Form 8-K/A	PU
09/03/22	U.S. STEM CELL, INC. Other Events (form 8-K/A)	AQ
09/03/22	U S Stem Cell : Mark Borman appointed Chairman of the Board of USRM	PU
09/03/22	U.S. STEM CELL, INC. : Other Events (form 8-K)	AQ
09/11/21	NOTE 2 - GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS	AQ
18/10/21	U S Stem Cell : USRM to Focus on Animal Health and Lead Pet-Care Innovation	PU
12/08/21	U S Stem Cell : NOTE 2 - GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS	AQ
16/07/21	U S Stem Cell : NOTE 2 - GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS	AQ
16/07/21	U S STEM CELL : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	AQ
08/06/21	U S Stem Cell : US Stem Cell Inc Reports Legal Appeal Results and Company Direction	PU
23/02/21	U S Stem Cell : Northstar Biotech and USRM BOD Members Reinvest in the Company	PU
21/01/21	U S Stem Cell : USRM Oral Argument in Appeal from FDA Enforcement Action	PU
30/09/20	U S Stem Cell : Confirms Date for Appeals Court Oral Arguments	PU
15/05/20	U.S. STEM CELL, INC. : Other Events (form 8-K)	AQ
31/03/20	U.S. STEM CELL, INC. : Other Events (form 8-K)	AQ
09/08/19	Corrected: USRM Posts Earnings for Second Quarter 2019	PR
07/05/19	US Stem Cell : USRM Posts Financial Results for First Quarter 2019	PR
26/04/19	US Stem Cell : Dr. Comella to Present at Paleo f(x) Conference in Austin, Texas	PR
13/03/19	US Stem Cell : USRM Posts Increase in Revenue and Profit Margin for 2018	PR
15/01/19	US Stem Cell : USRM Chief Science Officer Featured on One Radio Network	PR